Loading...
Loading...

Incorporated in 2004, Star Imaging and Path Lab Limited is a healthcare company providing diagnostic services across a wide range of medical tests. The company specializes in imaging services such as X-rays, ultrasounds, CT scans, MRIs, and laboratory tests, including blood tests, urine tests, and other specialized diagnostics. With advanced technology and experienced medical professionals, the company aims to offer accurate and timely reports to patients, helping healthcare providers in effective diagnosis and treatment. The company has a strong presence in multiple regions, offering services to both individuals and healthcare institutions.
Aug 8
Aug 12
Aug 13
Aug 14
Aug 14
Aug 18
Aug 8
Aug 12
Aug 13
Aug 14
Aug 14
Aug 18
| Category | Subscription | Status |
|---|---|---|
| QIB (Qualified Institutional Buyers) | 12.85x | Oversubscribed |
| NII (Non-Institutional Investors/HNI) | 4.38x | Oversubscribed |
| RII (Retail Individual Investors) | 2.32x | Oversubscribed |
| Total Subscription | 5.67x | Oversubscribed |
Last updated: Aug 12, 2025, 05:06 PM
Detailed breakdown of financial metrics across years
| Financial Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| 28.60 | ₹22.34 Cr | ₹5.81 Cr | - |
| Assets | ₹98.16 Cr | ₹81.64 Cr | ₹61.23 Cr |
| Net Worth | ₹47.15 Cr | ₹31.35 Cr | ₹18.93 Cr |
| Profit After Tax | ₹15.96 Cr | ₹12.45 Cr | ₹0.58 Cr |
| Reserves and Surplus | ₹33.65 Cr | ₹29.85 Cr | ₹17.43 Cr |
| Total Borrowing | ₹32.73 Cr | ₹30.64 Cr | ₹26.56 Cr |
| Total Income | ₹83.79 Cr | ₹79.97 Cr | ₹58.68 Cr |
Competitive advantages and positive aspects
| (Ex Market Maker) | 34,40,000 shares (aggregating up to ₹48.85 Cr) |
| [.] | |
| ₹10 per share | |
| ₹142 per share | |
| 1,000 Shares | |
| 1,35,00,000 shares | |
| 1,74,20,000 shares | |
| 48,92,000 shares (aggregating up to ₹69.47 Cr) | |
| 9,72,000 shares of ₹10 (aggregating up to ₹13.80 Cr) | |
| BSE SME | |
| IPO Date | August 8, 2025 to August 12, 2025 |
| Issue Type | Bookbuilding IPO |
| Net Offered to Public | 44,12,000 shares (aggregating up to ₹62.65 Cr) |
| Reserved for | |
| Sale Type | Fresh Capital-cum-Offer for Sale |
| Share Holding Post Issue | 71.92% |
| Share Holding Pre Issue | 100% |